ARWR - Arrowhead Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue9/30/20179/30/20169/30/2015
Total Revenue31,407.709158.333382
Cost of Revenue---
Gross Profit31,407.709158.333382
Operating Expenses
Research Development31,690.29841,454.45247,267.361
Selling General and Administrative32,022.8835,135.74536,609.622
Non Recurring-2,050.81710,142.786
Others4,690.443,260.0452,336.207
Total Operating Expenses-81,901.05996,355.976
Operating Income or Loss-36,995.909-81,742.726-95,973.976
Income from Continuing Operations
Total Other Income/Expenses Net2,202.886-243.673,306.336
Earnings Before Interest and Taxes-34,377.895-81,720.602-91,938.482
Interest Expense---
Income Before Tax-34,377.895-81,720.602-91,938.482
Income Tax Expense2.42.42.4
Minority Interest-555.188-555.188-555.188
Net Income From Continuing Ops-34,380.295-81,723.002-91,940.882
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-34,380.295-81,723.002-91,940.882
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-34,380.295-81,723.002-91,940.882